Selected Grants
Phase 3, Open-Label, Randomized, Two-Part Study Comparing Gedatolisib in Combination with Palbociclib and Fulvestrant to Standard-of-Care Therapies in Patients with HR-Positive, HER2-Negative Advanced Breast Cancer
Clinical TrialPrincipal Investigator · Awarded by Celcuity · 2022 - 2029Optimizing the Management and Outcomes for Cancer Survivors Transitioning to Follow-up Care
ResearchCo Investigator · Awarded by National Cancer Institute · 2020 - 2025Persistent Post-Mastectomy Pain: Randomized Clinical Trial of Targeted Pain Coping Skills Training (Targeted-PCST) with Mediational Analysis
ResearchCo Investigator · Awarded by National Institutes of Health · 2020 - 2025NCI National Clinical Trials Network (UG1)
Clinical TrialCo-Principal Investigator · Awarded by National Institutes of Health · 2019 - 2025A Mobile Health Behavioral Pain Intervention Protocol for Breast Cancer Patients with Pain in Medically Underserved Communities: A Randomized Controlled Trial
ResearchCo Investigator · Awarded by National Institutes of Health · 2020 - 2024Phase 3, Open-Label, Randomized, Two-Part Study Comparing Gedatolisib in Combination with Palbociclib and Fulvestrant to Standard-of-Care Therapies in Patients with HR-Positive, HER2-Negative Advanced Breast Cancer
Clinical TrialPrincipal Investigator · Awarded by Celcuity · 2022 - 2029Optimizing the Management and Outcomes for Cancer Survivors Transitioning to Follow-up Care
ResearchCo Investigator · Awarded by National Cancer Institute · 2020 - 2025Persistent Post-Mastectomy Pain: Randomized Clinical Trial of Targeted Pain Coping Skills Training (Targeted-PCST) with Mediational Analysis
ResearchCo Investigator · Awarded by National Institutes of Health · 2020 - 2025NCI National Clinical Trials Network (UG1)
Clinical TrialCo-Principal Investigator · Awarded by National Institutes of Health · 2019 - 2025A Mobile Health Behavioral Pain Intervention Protocol for Breast Cancer Patients with Pain in Medically Underserved Communities: A Randomized Controlled Trial
ResearchCo Investigator · Awarded by National Institutes of Health · 2020 - 2024PROSPECTIVE, LONGITUDINAL, NON-INTERVENTIONAL STUDY OF DISEASE BURDEN AND TREATMENT OF PATIENTS WITH LOW-RISK MYELOFIBROSIS (MF) OR HIGH-RISK ESSENTIAL THROMBOCYTHEMIA (ET) OR ET PATIENTS RECEIVING ET-DIRECTED THERAPY
ResearchPrincipal Investigator · Awarded by Incyte Corporation · 2017 - 2023Implementing Evidence-Based Interventions to Enhance Equity in Oncology Genomic Testing
ResearchCo Investigator · Awarded by V Foundation for Cancer Research · 2022 - 2023The DCN Passport: A Novel, Patient-Centered Approach to Improve Care for Gastric/Gastroesophageal Junction Cancer Across an Academic-Community Oncology Network
Clinical TrialCo Investigator · Awarded by Eli Lilly and Company · 2020 - 2023Advancing Cancer Care in the Rural Southeast: Enhancing Precision Medicine and Institutional Collaboration in Community Cancer Centers
ResearchPrincipal Investigator · Awarded by V Foundation for Cancer Research · 2021 - 2023Improving Adherence to Adjuvant Endocrine Therapy in Breast Cancer Patients
ResearchCo Investigator · Awarded by National Institutes of Health · 2016 - 2022Advancing Cancer Care in the Rural Southeast: Delivering Novel Therapies In Our Community Cancer Centers
ResearchPrincipal Investigator · Awarded by V Foundation for Cancer Research · 2019 - 2021A Self-Management Intervention for Women with Breast Cancer and Diabetes
ResearchCo Investigator · Awarded by American Cancer Society, Inc. · 2016 - 2020Metastatic Renal Cell Cancer Registry (MaRCC Registry)
ResearchPrincipal Investigator · Awarded by Pfizer, Inc. · 2015 - 2020Public Health Surveillance of Bleeding
ResearchCo Investigator · Awarded by Centers for Disease Control and Prevention · 2011 - 2016A Quality Improvement Approach to the Management of CLL--Research
ResearchPrincipal Investigator · Awarded by Genentech, Inc. · 2015 - 2016Caregiver-Assisting Coping Skills Training for Lung Cancer
ResearchCo Investigator · Awarded by National Institutes of Health · 2002 - 2008Spouse Guided Pain Management Training for Cancer Pain
ResearchCo Investigator · Awarded by National Institutes of Health · 2000 - 2003Spore In Breast Cancer
ResearchCo-Principal Investigator · Awarded by National Institutes of Health · 1995 - 1998External Relationships
- Pfizer Inc.
This faculty member (or a member of their immediate family) has reported outside activities with the companies, institutions, or organizations listed above. This information is available to institutional leadership and, when appropriate, management plans are in place to address potential conflicts of interest.